Financial Performance - The company's operating revenue for the third quarter was ¥537,821,981.51, a decrease of 7.59% compared to the same period last year[4] - The total profit for the quarter was ¥52,547,202.02, reflecting a decline of 4.16% year-over-year[4] - The net profit attributable to shareholders was ¥44,905,449.10, down 9.61% from the previous year[4] - The basic earnings per share were ¥0.216, a decrease of 12.20% compared to the same quarter last year[5] - Total operating revenue for the first three quarters of 2025 was CNY 1,653,828,387.36, a decrease of 3.7% compared to CNY 1,717,242,205.05 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was CNY 152,448,890.90, a slight decrease of 2.7% from CNY 156,982,164.95 in 2024[19] - Earnings per share for the first three quarters of 2025 was CNY 0.733, compared to CNY 0.761 in the same period of 2024[20] - Comprehensive income for the first three quarters of 2025 was CNY 152,742,372.60, slightly down from CNY 156,975,640.67 in 2024[20] - The company reported a total profit of CNY 7,786,934.74 for the first three quarters of 2025, compared to CNY 3,338,295.00 in 2024, which is an increase of about 133.5%[30] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,077,890,844.79, an increase of 16.93% from the end of the previous year[5] - Total current assets as of September 30, 2025, amounted to CNY 3,205,657,805.88, an increase from CNY 2,725,298,456.87 as of December 31, 2024, representing a growth of approximately 17.6%[13] - Total liabilities as of September 30, 2025, were CNY 1,718,304,387.74, compared to CNY 1,059,166,348.21, reflecting a significant increase of approximately 62.1%[15] - The company's total liabilities increased to ¥1,852,567,871.51 from ¥1,296,696,680.64, indicating a rise of about 43%[28] - The total equity remained stable at CNY 3,359,586,456.05, with no significant changes reported in the capital structure[15] Cash Flow - The cash flow generated from operating activities was ¥4,608,869.59[5] - Operating cash inflow totaled ¥1,067,470,739.05, a decrease from ¥1,188,764,199.00 in the previous period, reflecting a decline of approximately 10.2%[23] - Net cash flow from operating activities was ¥4,608,869.59, a significant improvement compared to a net outflow of ¥187,627,343.75 in the prior period[23] - Total cash inflow from operating activities in 2025 was CNY 1,899,632,456.21, compared to CNY 1,053,887,338.69 in 2024, marking an increase of about 80.3%[32] - The net cash flow from operating activities for the first three quarters of 2025 was CNY 283,097,408.83, up from CNY 90,142,281.03 in 2024, reflecting a growth of approximately 213.5%[32] Costs and Expenses - Total operating costs for the first three quarters of 2025 were CNY 1,489,405,767.21, down 4.4% from CNY 1,558,733,345.68 in 2024[18] - Research and development expenses for the first three quarters of 2025 were CNY 67,401,505.33, down 7.7% from CNY 73,168,490.95 in 2024[18] - The company reported a tax expense of CNY 26,375,901.82 for the first three quarters of 2025, compared to CNY 21,795,585.04 in 2024[19] Investments - The company received government subsidies totaling ¥1,281,087.67 during the reporting period[7] - The company’s long-term investments increased to CNY 91,686,397.25 from CNY 88,034,727.61, reflecting a growth of approximately 3%[14] - The cash outflow from investment activities in 2025 was CNY 153,024,788.50, compared to CNY 77,639,349.83 in 2024, representing an increase of approximately 96.5%[32] - The company received CNY 23,171,000.00 from investment activities in 2025, while no cash was received in the same period of 2024, marking a positive change in financing strategy[32] Other Financial Metrics - The company reported a decrease in the weighted average return on equity by 0.2 percentage points to 4.54%[5] - The company incurred a credit impairment loss of CNY 390,536.36 in 2025, compared to a loss of CNY 1,942,220.59 in 2024, indicating a reduction in losses[30] - The company reported a decrease in inventory, which stood at CNY 344,764,517.31, down from CNY 351,267,623.90, indicating a decline of about 1.9%[14] - The company’s accounts payable increased slightly to CNY 125,784,148.88 from CNY 123,767,302.98, indicating a growth of about 1.6%[15]

Core Viewpoint - The photovoltaic sector experienced a collective surge, with multiple companies such as Yao Pi Glass, Yijing Photovoltaic, and Longi Green Energy reaching their daily price limits, indicating strong market performance and investor interest in the industry [1][2]. Group 1: Market Performance - Yao Pi Glass saw a price increase of 10.04%, reaching 8.22, with a market capitalization of 61.44 billion [2]. - Yijing Photovoltaic's stock rose by 9.92% to 4.10, with a market cap of 48.53 billion [2]. - Longi Green Energy's shares increased by 9.38% to 19.83, with a market capitalization of 1502.73 billion [2]. - Trina Solar and JA Solar also experienced significant gains, with increases of 9.77% and 8.88%, respectively [2]. Group 2: Industry Developments - Reports indicate that important policies regarding capacity regulation in the photovoltaic sector are expected to be released, aimed at addressing internal competition issues [3]. - The National Development and Reform Commission and the State Administration for Market Regulation have announced measures to combat price disorder in the market [3]. Group 3: Institutional Insights - The photovoltaic industry is showing a unified attitude towards price self-discipline, with expectations for continued self-regulatory actions into the second half of 2025 [4]. - The "anti-involution" measures have led to a recovery in multi-crystalline silicon prices, with leading silicon material companies beginning to restore profits [4]. - The photovoltaic glass market has shown signs of recovery since August, with prices significantly rebounding from July lows, benefiting overall industry profitability [4].

Core Viewpoint - Yuanli Technology (sh603217) reached its daily limit up on October 14, 2025, with a price of 25.8 yuan, marking a 10.02% increase and a total market capitalization of 5.369 billion yuan [1] Summary by Relevant Sections - **Employee Stock Ownership Plan**: The employee stock ownership plan received over 99.8% approval, covering 111 core employees, including 7 executives. This indicates strong shareholder confidence in the company's future and aligns employee interests with the company's long-term development [2] - **Performance Improvement**: The company's net profit excluding non-recurring items increased by 9.08% year-on-year. Operating cash flow improved from a negative 49.07 million yuan in the previous year to 7 million yuan, indicating a significant enhancement in cash flow status [2] - **Cost Reduction**: Major raw material prices have decreased by 10% to 32%, which will significantly lower production costs and enhance profit margins [2] - **Governance Structure Optimization**: The company has optimized its governance structure by abolishing the supervisory board and transferring its functions to the audit committee, simplifying decision-making processes and improving operational efficiency. Several governance policies have been revised, including the introduction of a new market value management system [2] - **Market Sentiment and Technical Analysis**: Although specific capital flow data for the day was not obtained, the positive fundamentals may attract capital inflow. If the stock price breaks through key resistance levels, it could draw more investor attention, contributing to the stock's limit-up performance [2]

证券代码：603217 证券简称：元利科技 公告编号：2025-032 元利化学集团股份有限公司 2025 年员工持股计划第一次持有人会议决议公告 三、审议通过了《关于授权公司 2025 年员工持股计划管理委员会办理与本 次员工持股计划相关事项的议案》 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 元利化学集团股份有限公司（以下简称"公司"）2025 年员工持股计划第 一次持有人会议于 2025 年 10 月 9 日以现场结合通讯表决的方式召开。会议由公 司董事会秘书冯国梁先生召集和主持，出席本次会议的持有人 101 人，代表 2025 年员工持股计划份额 21,338,100.00 份，占公司 2025 年员工持股计划总份额的 78.40%。会议的召集和召开程序符合相关法律法规及公司 2025 年员工持股计划 （以下简称"本员工持股计划"）的有关规定，会议合法有效。经与会持有人审 议，形成如下决议： 一、审议通过了《关于设立公司 2025 年员工持股计划管理委员会的议案》 根据公司《2025年员工持股计划》和《202 ...

证券代码：603217 证券简称：元利科技 公告编号：2025-031 元利化学集团股份有限公司 关于召开2025年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 10 月 17 日（星期五）13:00-14:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 10 月 10 日（星期五）至 10 月 16 日（星期四）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 lixingang@yuanlichem.com 进行提问。公司将在说明会上对投资者普遍关注的 问题进行回答。 元利化学集团股份有限公司（以下简称"公司"）已于 2025 年 8 月 28 日发 布公司 2025 年半年度报告，为便于广大投资者更全面深入地了解公司 2025 年半 年度经营成果、财务 ...

Core Viewpoint - Yuanli Technology (元利科技) has officially signed a strategic cooperation memorandum with Lubrizol, a specialty chemicals company under Berkshire Hathaway, to collaborate in the personal care sector, focusing on the development and market application of bio-based and environmentally friendly new materials [1] Company Summary - Yuanli Technology is a leading enterprise in China's fine chemical industry, dedicated to the industrial application of green manufacturing and synthetic biology technology [1] - Lubrizol holds significant influence in the global specialty chemicals market, enhancing the partnership's potential impact [1] Industry Summary - The collaboration aims to build a more resilient and sustainable supply chain, focusing on forward-looking technological cooperation in new materials for personal care [1] - The partnership is expected to accelerate innovation processes through resource integration, providing more efficient and sustainable services to global customers, and promoting technological advancement and green transformation in the personal care industry [1]

603217 2025 本公司及董事会全体成员保证本员工持股计划及其摘要的内容真实、准确、 完整，不存在虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性、完整 性承担个别和连带的法律责任。 本方案主要条款与公司2025年8月28日公告的公司2025年员工持股计划（草 案）及其摘要内容一致。 1 一、元利化学集团股份有限公司2025年员工持股计划需经公司股东大会审议 通过后方可实施，本员工持股计划已获得公司股东大会批准。 二、有关本员工持股计划的具体资金来源、出资比例、实施方案等属初步 结果，能否完成实施，存在不确定性。 三、若员工认购资金较低，则本员工持股计划存在不能成立的风险；若员 工认购资金不足，本员工持股计划存在低于预计规模的风险。 四、本员工持股计划实施所产生的相关成本或费用的摊销可能对公司相关 年度净利润有所影响。 五、股票价格受公司经营业绩、宏观经济周期、国际/国内政治经济形势及 投资者心理等多种复杂因素影响。因此，股票交易是有一定风险的投资活动， 投资者对此应有充分准备。 六、本员工持股计划中有关公司业绩考核指标的描述不代表公司的业绩预 测，亦不构成业绩承诺。 七、公司后续将根据规定披露相关 ...

关于元利化学集团股份有限公司 2025 年第一次临时股东大会的 法律意见书 致：元利化学集团股份有限公司（贵公司） 北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 国枫律股字[2025]A0458 号 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2025 年第一次临时股东大会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简称 "《股东会规则》"）、《律师事务所从事证券法律业务管理办法》（以下简称"《证券法律 业务管理办法》"）、《律师事务所证券法律业务执业规则（试行）》（以下简称"《证券法 律业务执业规则》"）等相关法律、行政法规、规章、规范性文件及《元利化学集团股份 有限公司章程》（以下简称"《公司章程》"）的规定，就本次会议的召集与召开程序、 召集人资格、出席会议人员资格、会议表决程序及表决结果等事宜，出具本 ...

一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 9 月 16 日 (二)股东大会召开的地点：潍坊市昌乐县朱刘街道工业园公司会议室 证券代码：603217 证券简称：元利科技 公告编号：2025-030 元利化学集团股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 131 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 135,744,233 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股份 | 66.1497 | | 总数的比例（%） | | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，公司董事长刘修华先生主持会议，会议采 取现场和网络投票相结合的方式表决。会议的召集、召开及表决方式符合《公司 法》 ...

关于元利化学集团股份有限公司 实施 2025 年员工持股计划的法律意见书 国枫律证字[2025]AN145-1 号 北京国枫律师事务所 GRANDWAY 北京国枫律师事务所 Grandway Law Offices 北京市东城区建国门内大街 26 号新闻大厦 7 层 邮编: 100005 电话（Tel） 010-88004488/66090088 传真(Fax): 010-66090016 北京国枫律师事务所 关于元利化学集团股份有限公司 实施 2025 年员工持股计划的法律意见书 国枫律证字[2025]AN145-1 号 致: 元利化学集团股份有限公司（以下称"贵公司"或"公司"） 根据《中华人民共和国公司法》(以下称"《公司法》")、《中华人民共和国证 券法》、中国证券监督管理委员会(以下称"中国证监会")发布的《关于上市公 司实施员工持股计划试点的指导意见》(以下称"《试点指导意见》")、上海证券 交易所《上海证券交易所上市公司自律监管指引第1号--规范运作》(以下称"《监 管指引第 1 号》")的相关规定,北京国枫律师事务所(以下称"本所")接受贵 公司的委托,就贵公司拟实施的 2025年员工持股计划 ...